EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Relationship between murine macrophage Fc receptor-mediated phagocytic function and competency for activation for non-specific tumor cytotoxicity


Immunobiology 171(3): 220-233
Relationship between murine macrophage Fc receptor-mediated phagocytic function and competency for activation for non-specific tumor cytotoxicity
The relationship between Fc receptor (FcR) function and activation of murine macrophage populations for non-specific tumor cytotoxicity was studied. Oil-elicited inflammatory peritoneal macrophages (PM phi) from C3HeB/FeJ mice had higher FcR function upon harvest than resident PM phi from the same strain or elicited PM phi from genetically deficient C3H/HeJ mice. C3HeB/FeJ inflammatory PM phi were uniformly responsive to activation by MAF and the complement activators: LPS, Poly I:C, cobra venom factor (CVF) and zymosan for tumoricidal activity. Resident cells from the same strain and C3H/HeJ-elicited PM phi were uniformly unresponsive to the same activators. In vitro culture of C3HeB/FeJ resident PM phi with fetal bovine serum for 24-48 h produced unregulation of FcR function which coincided with a conversion from an unresponsive to a responsive state for tumoricidal activity. Reconstitution of the FcR function of C3H/HeJ-elicited PM phi during 24-48 h culture with lymphokine or Poly I:C also coincided with the restoration of responsiveness to activation by LPS, CVF, and zymosan for tumor cytotoxicity. Thus, the consistent temporal relationship between upregulated FcR function and the capacity of macrophages to respond to activation for non-specific tumoricidal activity may be more than coincidental. Preincubation of responsive C3HeB/FeJ-elicited PM phi with insoluble immune complex or heat-aggregated IgG was shown to blockade FcR-mediated phagocytosis and to abrogate LPS-mediated tumoricidal activity. Interestingly, FcR blockade by IgG-opsonized sheep erythrocyte conjugates selectively inhibited activation by MAF, LPS, and Poly I:C, but had no inhibitory effect on activation by CVF or zymosan. Similar blockade of C3b receptors produced an identical pattern of selective inhibition of activation. This selective inhibition of non-specific tumoricidal activity by FcR/C3bR blockade suggests the existence of two pathways for antibody-independent activation of macrophages.


Accession: 041221594

PMID: 3519439

DOI: 10.1016/S0171-2985(86)80006-7



Related references

Tumor-derived recognition factor promotes IFN-gamma receptor and TNF receptor mRNA synthesis for increased NOS mRNA and no-mediated tumor cytotoxicity on murine macrophage. FASEB Journal 9(4): A1038, 1995

Lymphokine macrophage activation factors induction of nonspecific macrophage mediated cytotoxicity against tumor cell and microbial targets. Chiao, J W (Ed ) Immunology Series, Vol 40 Biological Response Modifiers And Cancer Therapy Xv+444p Marcel Dekker, Inc : New York, New York, Usa; Basel, Switzerland Illus 335-362, 1988

Effects of tumor-promoting agents on cells of the murine immune system: inhibition of antibody synthesis and of macrophage-mediated tumor cell cytotoxicity. Carcinogenesis; A Comprehensive Survey 7: 637-642, 1982

Differential expression of murine macrophage-mediated tumor cytotoxicity induced by interferons. Cancer Research 47(11): 2804-2808, 1987

Soluble factor from murine bladder tumor-2 cell elevates nitric oxide production in macrophages and enhances the taxol-mediated macrophage cytotoxicity on tumor cells. Cancer Investigation 21(5): 708-719, 2003

Non-T-cell-mediated cytotoxicity in MSV tumor-bearing mice. III. Macrophage-mediated cytotoxicity against autochthonous MSV tumor-isolated target cells. International Journal of Cancer 25(4): 535-541, 1980

Activation of macrophage tumor cytotoxicity by the synergism of 2 t cell derived lymphokines immune interferon and macrophage cytotoxicity inducing factor 2. European Journal of Immunology 15(1): 18-24, 1985

Murine tumor cell lysis by antibody-dependent macrophage-mediated cytotoxicity using syngeneic monoclonal antibodies. Cancer Research 45(4): 1663-1668, 1985

Augmentation of recombinant interleukin 2 dependent murine macrophage mediated tumor cytotoxicity by recombinant tumor necrosis factor alpha. Immunology & Cell Biology 67(6): 433-436, 1989

Activation of macrophage tumor cytotoxicity by the synergism of two T cell-derived lymphokines: immune interferon (IFN-gamma) and macrophage cytotoxicity-inducing factor 2 (MCIF2). European Journal of Immunology 15(1): 18-24, 1985